Total trials
99
Active
41
Phase 3
1
Total enrollment
1,167,785
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Intra-articular Lidocaine | — | — | — | — | — | 1 |
Next readouts
- 2027-08-01
Top conditions
- Healthy8
- Breast Cancer5
- Low Back Pain4
- Dementia4
- HIV3
- Muscle Weakness3
- Physical Inactivity3
- Sedentary Behavior3
Frequently asked questions about University of Central Florida
- How many clinical trials does University of Central Florida have on ClinicalTrials.gov?
- University of Central Florida is listed as the lead sponsor on 99 clinical trials in ClinicalTrials.gov, 41 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Central Florida's trials are in Phase 3?
- 1 of University of Central Florida's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does University of Central Florida focus on?
- University of Central Florida's most-studied conditions on ClinicalTrials.gov are Healthy, Breast Cancer, Low Back Pain, Dementia, HIV.
- When are University of Central Florida's next clinical trial readouts?
- University of Central Florida has 1 upcoming primary-completion readout tracked here; the soonest is “Quadriceps Motor Unit Adaptation to Simulated Knee Injury”, expected around 2027-08-01.